Population Screening Market Report 2026

Population Screening Market Overview

• Population Screening market size has reached to $31.39 billion in 2025 • Expected to grow to $44.61 billion in 2030 at a compound annual growth rate (CAGR) of 7.4% • Growth Driver: The Surge Of Population Screening In Addressing The Growing Cancer Burden • Market Trend: Innovative Newborn Mass Screening Services In Population Health • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Population Screening Market?

Population screening is a process of assessing the prevalence of a particular trait or disease in the entire population or a subgroup of people. The goal of population screening is to accurately predict which individuals in a group are at risk of developing a disease, which is different from diagnostic testing. The main products of population screening are hardware equipment, testing or lab, analytics, or interpretation. Hardware plays an important role in population screening and provides the tools and equipment required for performing screening tests, gathering data, and providing healthcare services. Population screening can be done for males and females ages less than 15, 15 to 65, and ages 65 and above by various businesses including hospitals, research institutes, and diagnostic labs.

What Is The Population Screening Market Growth Forecast?

The population screening market size is expected to see strong growth in the next few years. It will grow to $44.61 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to rising investments in precision screening technologies, increasing use of population-level health analytics, expansion of national screening programs, growing integration of digital diagnostics, increasing focus on preventive healthcare models. Major trends in the forecast period include increasing use of genomic screening programs, rising adoption of AI-based risk assessment tools, growing expansion of preventive health screening, integration of advanced diagnostic technologies, enhanced data interpretation capabilities.

Global Population Screening Market Segmentation

1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation 2) By Gender: Male, Female 3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above 4) By Business: Hospitals, Research Institutes, Diagnostic Labs Subsegments: 1) By Hardware Equipment: Diagnostic Devices, Sample Collection Devices, Imaging Equipment 2) By Testing Or Lab: Laboratory Testing Kits, Point-Of-Care Testing, Blood And Urine Testing Services 3) By Analytics Or Interpretation: Software Solutions For Data Analysis, Interpretation Services, Reporting Tools

What Is The Driver Of The Population Screening Market?

The rising prevalence of cancer is expected to propel the growth of the population screening market going forward. Cancer is a condition in which specific cells in the human body grow uncontrollably and can spread to other parts of the body, posing significant health risks. Population screening helps in the early detection of cancer, improving treatment outcomes and patient prognosis. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the rising prevalence of cancer is driving the growth of the population screening industry.

Key Players In The Global Population Screening Market

Major companies operating in the population screening market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., LabPLUS

Global Population Screening Market Trends and Insights

Major companies operating in the population screening market are innovating advanced services, such as newborn mass screening, to enhance early detection and improve infant health outcomes. Newborn mass screening is a public health program where newborns are tested shortly after birth for a range of genetic, metabolic, hormonal, and functional disorders that are not apparent at birth but can lead to severe health problems if left untreated. For instance, in May 2024, Shimadzu Techno-Research Inc., a contract analysis company and subsidiary of Shimadzu Corporation, a Japan-based manufacturer of precision instruments, launched a new contract service that performs polymerase chain reaction (PCR) testing for expanded newborn mass screening. This service will screen for combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA), which currently affect a small percentage of newborns but require immediate intervention upon diagnosis.

What Are Latest Mergers And Acquisitions In The Population Screening Market?

In January 2024, Natera, a US-based biotechnology company, acquired Invitae for an undisclosed amount. With this acquisition, Natera aims to expand its capabilities in non-invasive prenatal and carrier screening, enhancing its service offerings and supporting more patients and providers. Invitae is a US-based company that provides advanced genetic testing services, including population screening.

Regional Outlook

North America was the largest region in the population screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Population Screening Market?

The population screening market consists of revenues earned by entities by providing services such as next-generation sequencing (NGS) and microarray-based genotyping, imaging tests, mammography screening, colonoscopy screening, cholesterol screening, and blood pressure screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The population screening market also includes sales of smartphone-based biosensors, kits, and chips, which are used in providing population screening services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Population Screening Market Report 2026?

The population screening market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the population screening industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.